Treatment Guideline: CDK4/6 Inhibitors after Progression on CDK4/6 Inhibitor in Patients With Hormone Receptor-Positive/HER2-negative Advanced Breast Cancer
Treatment Guideline: Capivasertib Plus Fulvestrant for Advanced Estrogen Receptor-Positive Breast Cancer - Updated in 2025
Treatment Guideline: Trastuzumab Deruxtecan (T-DXd) for Metastatic, HER2-Low and HER2-Ultralow Breast Cancer
Treatment Guideline: Patients With a History of Breast Cancer who Desire Pregnancy
Treatment Guideline: Sacituzumab Govitecan for Metastatic, HR-Positive, HER2-Negative Breast Cancer
Treatment Guideline: Elacestrant for Advanced Estrogen Receptor-Positive Breast Cancer
Robotic Bronchoscopy
Breast Oncology Research Presentations Schedule
Temple Healthy Chest Initiative: a New Approach to Lung Cancer Screening
Temple – Fox Chase Thoracic Surgery
Treatment Guideline: Adjuvant Olaparib for BRCA1/2 Variant Carriers - Updated in 2026
Treatment Guideline: Reflex Testing of OncotypeDX for Early Stage Breast Cancer
ESMO Congress 2022 Preview
Transforming Cancer
Treatment Guideline: Pembrolizumab for Early-Stage Triple-Negative Breast Cancer - Updated in 2026
Showing 16 - 30 of 59 results
Previous| 1 | 2 | 3 | 4 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
